(5)On 13 January 2021, Delegated Regulation (EU) 2016/161 was amended by Commission Delegated Regulation (EU) 2021/457note to provide a derogation from the requirement to decommission unique identifiers of products exported to the United Kingdom until 31 December 2021. This derogation was intended to ensure the supply of medicinal products to small markets historically dependent on the United Kingdom, i.e. Northern Ireland, Cyprus, Ireland and Malta. In those small markets historically dependent on the United Kingdom, many medicinal products were and continue to be purchased from the United Kingdom by wholesalers not holding manufacturing and importation authorisations and therefore unable to meet the importation requirements laid down in Directive 2001/83/EC and Delegated Regulation (EU) 2016/161.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.